Regulatory and Legal Notices




410 NEW ZEALAND GAZETTE, No. 16 12 FEBRUARY 2009

Boron including borax and boric acid; in medicines for internal use containing 6 milligrams or less per recommended daily dose; for dermal use other than paediatric use in medicines containing 0.35% or less; when present as an excipient

Etidronic acid; in medicines for external use containing 1% or less

Iron; for oral use in packs containing 24 milligrams or less per recommended daily dose either in medicines containing not more than 5 milligrams per dose unit or in medicines containing more than 5 milligrams per dose unit and in packs containing not more than 750 milligrams of iron; in parenteral nutrition replacement preparations

Liquorice; deglycyrrhizinised

Lithium; for dermal use in medicines containing 0.01% or less; when present as an excipient in medicines for dermal use containing 0.25% or less

Lobeline; in medicines for smoking or burning

Methyl salicylate; for external use; for internal use when present as an excipient in medicines containing 1.04% or less per dose form

Nicotinamide

Nicotinic acid; in medicines containing 100 milligrams or less per dose form

Octocog alfa

Oxiconazole; for dermal use in medicines for tinea pedis only

Perflutren

Polysulfated glycosaminoglycans; except in injections other than intraocular viscoelastic products

Potassium; for internal use: in slow release or enteric coated forms; in medicines containing more than 100 milligrams per recommended dose except in medicines for oral rehydration therapy, parenteral nutrition replacement, dialysis; except in glucosamine sulfate complexed products containing 600 milligrams or less of potassium chloride per recommended dose

Pyrethrins; in medicines containing 10% or less

Pyridoxal; in medicines containing 200 milligrams or less per recommended daily dose

Pyridoxamine; in medicines containing 200 milligrams or less per recommended daily dose

Pyrithione zinc; for treatment of the scalp in medicines containing 2% or less

*Ranitidine; in medicines containing not more than 150 milligrams per dose unit which have received the consent of the Minister or the Director-General to their distribution as general sale medicines and which are sold in the manufacturer’s original pack containing not more than 7 day’s supply

Salicylic acid; in medicines containing 40% or less

Selenium; for oral use in medicines containing 150 micrograms or less per recommended daily dose; for external use in medicines containing 3.5% or less of selenium sulphide

Vitamin A; for internal use in medicines containing 3000 micrograms or less of retinol equivalents per recommended daily dose; in parenteral nutrition replacement preparations; for external use in medicines containing 1% or less

Vitamin D; for external use; for internal use in medicines containing 25 micrograms or less per recommended daily dose; in parenteral nutrition replacement preparations

*Zinc; for external use except in medicines containing more than 5% of zinc chloride; for internal use in medicines containing 25 milligrams or less per recommended daily dose; for internal use in medicines containing 50 milligrams or less and more than 25 milligrams per recommended daily dose in packs which have received the consent of the Minister or the Director-General to their distribution as general sale medicines and which are sold in the manufacturer’s original pack and when labelled with a statement that the product may be dangerous if taken in large amounts or for long periods; in parenteral nutrition replacement preparations

*Regulation 20 of the Medicines Regulations 1984 requires that all medicines sold without a practitioner’s prescription must include a consumer information panel on the label. Further, all material changes to a medicine (including changes to labelling) must be notified to the Director-General of Health in accordance with section 24 of the Medicines Act 1981.

Dated this 9th day of February 2009.

STEWART JESSAMINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health.

go1195

Inland Revenue

Tax Administration Act 1994

Notice of Product Ruling

  1. This is a notice of a product ruling made under section 91F of the Tax Administration Act 1994.

  2. Product ruling No. 08/03 was issued on 4 December 2008. It relates to the supply of services relating to the development and maintenance of NOVA software and provision of network services by Capital Market Solutions NZ Limited to its New Zealand customers. The ruling will appear in Inland Revenue’s Tax Information Bulletin, Vol. 21, No. 2, of March 2009.

  3. A copy of the ruling may be obtained by writing to the Team Manager (Technical Services), Office of the Chief Tax Counsel, National Office, Inland Revenue, PO Box 2198, Wellington.

GARY DICK, Team Manager (Technical Services), Office of the Chief Tax Counsel.

go1156

Justice

Sentencing Act 2002

Order for Confiscation of Motor Vehicle

Pursuant to sections 128 and 129 of the Sentencing Act 2002, an order was made in the Opotiki District Court on 5 February 2009, for the confiscation of the following motor vehicle:

1990 Honda Accord, Registration No. TJ9174.

Against: Duke Hudson.

Anyone who has a legal interest in this vehicle should contact the Court urgently (telephone (07) 315 1141) as the Registrar may sell the vehicle.



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2009, No 16





✨ LLM interpretation of page content

🏥 Medicines for General Sale (continued from previous page)

🏥 Health & Social Welfare
9 February 2009
Medicines, General Sale, Reclassification, Regulations
  • STEWART JESSAMINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health

💰 Notice of Product Ruling

💰 Finance & Revenue
Tax Administration, Product Ruling, Capital Market Solutions NZ Limited, NOVA software
  • GARY DICK, Team Manager (Technical Services), Office of the Chief Tax Counsel

⚖️ Order for Confiscation of Motor Vehicle

⚖️ Justice & Law Enforcement
5 February 2009
Sentencing Act, Motor Vehicle Confiscation, Opotiki District Court, Honda Accord
  • Duke Hudson, Subject of motor vehicle confiscation order